These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 12483414
1. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Engler H, Lundberg PO, Ekbom K, Nennesmo I, Nilsson A, Bergström M, Tsukada H, Hartvig P, Långström B. Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):85-95. PubMed ID: 12483414 [Abstract] [Full Text] [Related]
2. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). Henkel K, Zerr I, Hertel A, Gratz KF, Schröter A, Tschampa HJ, Bihl H, Büll U, Grünwald F, Drzezga A, Spitz J, Poser S. J Neurol; 2002 Jun; 249(6):699-705. PubMed ID: 12111302 [Abstract] [Full Text] [Related]
3. Imaging astrocytosis with PET in Creutzfeldt-Jakob disease: case report with histopathological findings. Engler H, Nennesmo I, Kumlien E, Gambini JP, Lundberg P, Savitcheva I, Långström B. Int J Clin Exp Med; 2012 Jun; 5(2):201-7. PubMed ID: 22567182 [Abstract] [Full Text] [Related]
4. Multitracer study in Heidenhain variant of Creutzfeldt-Jakob disease: mismatch pattern of cerebral hypometabolism and perfusion imaging. Pichler R, Ciovica I, Rachinger J, Weiss S, Aichner FT. Neuro Endocrinol Lett; 2008 Feb; 29(1):67-8. PubMed ID: 18283251 [Abstract] [Full Text] [Related]
5. Metabolic Changes Detected by 18F-FDG PET in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease. Lu H, Jing D, Chen Y, Cui C, Gao R, Wang L, Liang Z, Chen K, Wu L. J Alzheimers Dis; 2020 Feb; 77(4):1513-1521. PubMed ID: 32925055 [Abstract] [Full Text] [Related]
6. FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation. Renard D, Castelnovo G, Collombier L, Thouvenot E, Boudousq V. Prion; 2017 Nov 02; 11(6):440-453. PubMed ID: 29099286 [Abstract] [Full Text] [Related]
7. Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis. Renard D, Vandenberghe R, Collombier L, Kotzki PO, Pouget JP, Boudousq V. J Neurol; 2013 Dec 02; 260(12):3055-64. PubMed ID: 24068371 [Abstract] [Full Text] [Related]
16. Amyloid- and FDG-PET in sporadic Creutzfeldt-Jakob disease: Correlation with pathological prion protein in neuropathology. Matías-Guiu JA, Guerrero-Márquez C, Cabrera-Martín MN, Gómez-Pinedo U, Romeral M, Mayo D, Porta-Etessam J, Moreno-Ramos T, Carreras JL, Matías-Guiu J. Prion; 2017 May 04; 11(3):205-213. PubMed ID: 28509609 [Abstract] [Full Text] [Related]
20. A longitudinal 18F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt-Jakob disease linked to G114V mutation. Chu M, Chen Z, Nie B, Liu L, Xie K, Cui Y, Chen K, Rosa-Neto P, Wu L. J Neurol; 2022 Nov 04; 269(11):6094-6103. PubMed ID: 35864212 [Abstract] [Full Text] [Related] Page: [Next] [New Search]